All the information you need to install and to download Refinitiv Eikon. Direct link to test if your system can run Refinitiv Eikon.

Eikon is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. We are passionate about novel therapeutics and share the belief …

Find the latest Eikon Therapeutics, Inc. (EIKN) stock quote, history, news and other vital information to help you with your stock trading and investing.

1 day ago · A detailed overview of Eikon Therapeutics, Inc. (EIKN) stock, including real-time price, chart, key statistics, news, and more.

Feb 5, 2026 · At $381 million, Eikon looks set to be the largest biotech IPO since 2024, overtaking Aktis Oncology’s $318 million offering last month. The California-based company has already set out its …

Feb 4, 2026 · Eikon Therapeutics, a star-studded biotechnology startup that raised more than $1 billion in venture funding, said Wednesday it has secured $381 million more through an initial public offering.

Jan 9, 2026 · Eikon Therapeutics filed for an initial public offering. The late-stage clinical biopharmaceutical company didn't disclose in its Friday filing the price or amount of shares it would …

Eikon Therapeutics, Inc. (EIKN) announced the pricing of its upsized initial public offering of 21,177,600 shares of common stock at $18.00 per share. The biopharmaceutical company granted ...

Eikon is a set of software products set to be fully replaced by LSEG Workspace in 2025. It is designed for financial professionals to monitor and analyse financial information. It provides access to real time …

Feb 5, 2026 · Eikon was founded in 2019 by Chemistry Nobel Prize winner Eric Betzig, along with Xavier Darzacq, Luke Lavis and Robert Tjian, and is developing a pipeline of experimental treatments for …